#cancerevo — Public Fediverse posts

Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#Cancer #JanusEffect #AML #ABM
https://www.nature.com/articles/s41540-026-00675-6?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20260320&utm_content=10.1038/s41540-026-00675-6

Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#Cancer #JanusEffect #AML #ABM
https://www.nature.com/articles/s41540-026-00675-6?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20260320&utm_content=10.1038/s41540-026-00675-6

Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#Cancer #JanusEffect #AML #ABM
https://www.nature.com/articles/s41540-026-00675-6?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20260320&utm_content=10.1038/s41540-026-00675-6

Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#Cancer #JanusEffect #AML #ABM
https://www.nature.com/articles/s41540-026-00675-6?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20260320&utm_content=10.1038/s41540-026-00675-6

Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#Cancer #JanusEffect #AML #ABM
https://www.nature.com/articles/s41540-026-00675-6?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20260320&utm_content=10.1038/s41540-026-00675-6

Congrats Dr. @alexsteinresearch.bsky.social and also Alex's PhD supervisor @benjaminwerner.bsky.social for an excellent body of doctoral work pushing the frontiers of #mathonco and #cancerevo

Exciting and thought provoking talk today at #Moffitt #IMO by
Itai Yanai with a persuasive argument in favor of a non-genetic modular view of cancer evolution

#MathOnco #Plasticity #CancerEvo

Time for an #introduction:
I am an associate professor at the #MoffittCancerCenter in Florida. My group #CancerEvo and I are interested in #CancerEvolution and #CancerEcology and how those impact the #evolution of #cancer #resistance to #treatment. We do that by working very closely with cancer #biologists and clinicians using #math #mathonco models.

I am also married to the lovely @pbiwan. A #neuroscientist and #scicomm professional whom I help with the #2Scientist podcast